CytomX Therapeutics Inc (CTMX)
5.13
+3.50
(+214.72%)
USD |
NASDAQ |
May 01, 16:00
4.37
-0.76
(-14.81%)
After-Hours: 04:51
CytomX Therapeutics Research and Development Expense (Quarterly): 19.39M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 19.39M |
| September 30, 2023 | 16.45M |
| June 30, 2023 | 20.67M |
| March 31, 2023 | 21.18M |
| December 31, 2022 | 19.56M |
| September 30, 2022 | 30.37M |
| June 30, 2022 | 31.16M |
| March 31, 2022 | 30.56M |
| December 31, 2021 | 36.58M |
| September 30, 2021 | 29.14M |
| June 30, 2021 | 26.10M |
| March 31, 2021 | 22.37M |
| December 31, 2020 | 22.01M |
| September 30, 2020 | 24.05M |
| June 30, 2020 | 24.07M |
| March 31, 2020 | 42.81M |
| December 31, 2019 | 36.44M |
| September 30, 2019 | 27.97M |
| June 30, 2019 | 30.84M |
| Date | Value |
|---|---|
| March 31, 2019 | 36.38M |
| December 31, 2018 | 28.31M |
| September 30, 2018 | 27.55M |
| June 30, 2018 | 25.55M |
| March 31, 2018 | 22.46M |
| December 31, 2017 | 20.70M |
| September 30, 2017 | 28.92M |
| June 30, 2017 | 28.08M |
| March 31, 2017 | 14.58M |
| December 31, 2016 | 15.35M |
| September 30, 2016 | 13.34M |
| June 30, 2016 | 12.70M |
| March 31, 2016 | 13.36M |
| December 31, 2015 | 9.503M |
| September 30, 2015 | 9.157M |
| June 30, 2015 | 5.033M |
| March 31, 2015 | 4.664M |
| December 31, 2014 | 4.339M |
| September 30, 2014 | 3.916M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
16.45M
Minimum
Sep 2023
42.81M
Maximum
Mar 2020
26.93M
Average
26.10M
Median
Jun 2021
Research and Development Expense (Quarterly) Benchmarks
| Ocular Therapeutix Inc | 16.20M |
| Bristol-Myers Squibb Co | 2.695B |
| ACADIA Pharmaceuticals Inc | 66.74M |
| Cytokinetics Inc | -- |
| Calidi Biotherapeutics Inc | 3.958M |